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Hung-Wen Yeh1*, Edward F Ellerbeck2 and Jonathan D Mahnken1Abstract
Background: GEE and mixed models are powerful tools to compare treatment effects in longitudinal smoking
cessation trials. However, they are not capable of assessing the relapse (from abstinent back to smoking)
simultaneously with cessation, which can be studied by transition models.
Methods: We apply a first-order Markov chain model to analyze the transition of smoking status measured every
6 months in a 2-year randomized smoking cessation trial, and to identify what factors are associated with the
transition from smoking to abstinent and from abstinent to smoking. Missing values due to non-response are
assumed non-ignorable and handled by the selection modeling approach.
Results: Smokers receiving high-intensity disease management (HDM), of male gender, lower daily cigarette
consumption, higher motivation and confidence to quit, and having serious attempts to quit were more likely to
become abstinent (OR = 1.48, 1.66, 1.03, 1.15, 1.09 and 1.34, respectively) in the next 6 months. Among those who
were abstinent, lower income and stronger nicotine dependence (OR = 1.72 for≤ vs. > 40 K and OR= 1.75 for first
cigarette≤ vs. > 5 min) were more likely to have relapse in the next 6 months.
Conclusions: Markov chain models allow investigation of dynamic smoking-abstinence behavior and suggest that
relapse is influenced by different factors than cessation. The knowledge of treatments and covariates in transitions
in both directions may provide guidance for designing more effective interventions on smoking cessation and
relapse prevention.
Trial Registration: clinicaltrials.gov identifier: NCT00440115Background
Smoking studies typically hypothesize intervention
effects at a particular time point and analysis is per-
formed in a cross-sectional manner using “time-naïve”
approaches, e.g. the Pearson chi-square test or logistic
regression. These approaches only use the outcome
measures at the given time points, and appear to be ap-
propriate when the research question focuses on these
time point, or for short term smoking interventions with
brief follow-up when smoking cessation is viewed as an
acute, unidirectional problem (either smokers quit or
they don’t). However, longitudinal studies often involve* Correspondence: hyeh@kumc.edu
1Department of Biostatistics, The University of Kansas Medical Center, Kansas
City, Kansas 66160
Full list of author information is available at the end of the article
© 2012 Yeh et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the orcomparisons at multiple time points, and concern
whether the intervention effects vary across time, which
is beyond these “time-naïve” methods. Moreover, smok-
ing cessation is increasingly being recognized as a dy-
namic process where people quit, relapse, and quit
again, often with repeated cycles over years. Applying
‘time-naive’ approaches in these circumstances ignores
this dynamic natural history of smoking cessation.
To address these concerns, researchers have proposed
to use generalized estimating equations (GEE) and gen-
eralized linear mixed-effects models (GLMM) [1]. Both
GEE and GLMM use repeated outcome measures and
take the intra-personal association into account, and
provide a means to comparing intervention effects at
each time point and to examining whether the effects
vary over time [2]. GEE provides population-averaged. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in standard logistic regression models. In contrast to
GEE, GLMM is a subject-specific model. It estimates the
probability that an individual would be abstinent (or
smoking) at a given time point, allowing different pro-
pensity of abstinence (the random effects) among indivi-
duals. The two approaches also differ in other aspects,
including the robustness or sensitivity to the assump-
tions of correlation structures and missing mechanisms
[2]. Despite the differences, these two methods are in-
herently uni-directional, in the sense that they focus on
the outcome measure of abstinence (or smoking) across
time from smoking at baseline. For instance, suppose
GEE suggests 10% of the participants are not smoking at
time 1 and also 15% at time 2, which suggest an increase
in abstinence rate. However, these numbers do not indi-
cate whether the 10% subjects at time 1 continued ab-
stinent until time 2 and another 5% smokers at time 1
stopped smoking at time 2, or all the 10% subjects at
time 1 regressed to smoking at time 2 and another 15%
smokers at time 1 became abstinent at time 2, or some
of the 10% at time 1 remained abstinent into time 2 and
some of the 90% smokers at time 1 turned abstinent at
time 2. Similarly, suppose GLMM suggest an individual’s
chance of abstinence is 10% at time 1 and 15% at time 2.
This information does not tell how likely this individual
would have relapse because relapse refers to a condition
that an individual was previously abstinent. In other
words, neither GLMM nor GEE is capable of modeling
relapse and estimating this conditional probability of re-
gression to smoking given abstinent at the previous time
point.
On the other hand, a third method known as transi-
tion models provides a means to simultaneously investi-
gate transitions in both directions from smoking to
abstinent and from abstinent to smoking. Transition
models provide the capability of identifying factors that
might work differently in one direction versus the other.
Through characterizing factors associated with cessation
and those with relapse, we may be able to design more
effective interventions for both smoking cessation and
relapse prevention. Transition models are a family of
models that characterize transition patterns in longitu-
dinal studies. In these methods, the outcome measures
are often countable states (e.g. smoking and abstinent
can be the only two states that an observation can take).
Models developed to handle outcomes observed at a set
of scheduled time points are known as discrete-time
models [3]. A common model is the discrete-time first-
order Markov chain. It assumes that the future state will
depend only on the current state but not the entire tran-
sition history, and transition probabilities from one state
to another do not vary over time. With these two
assumptions, we may summarize the transition ofsmoking status through the entire study window by a
matrix with four probabilities: from smoking to smoking,
from smoking to abstinent, from abstinent to abstinent,
and from abstinent to smoking. Although the foundation
of transition models is built on stochastic processes
which tobacco researchers have seldom used, the imple-
mentation is straightforward when data are completely
observed. It relies on counting the numbers of transi-
tions from one state to another, and jointly models mul-
tiple logistic regression models, which most tobacco
researchers are familiar with. See details in the Methods
section.
In this article, we apply a non-homogeneous first-
order Markov transition model to evaluate the transition
of smoking behavior in a randomized smoking cessation
trial KanQuit [4] in which smoking was addressed as a
chronic illness and smokers underwent repeated inter-
ventions over a two year period of time. We also identify
potential factors associated with transitions from smok-
ing to not smoking (abstinence) and the factors asso-
ciated with the other direction (relapse). We first
perform the analysis using the available data alone. We
consider the non-responses, particularly those due to
lost-to-follow or consent withdraws, might be related to
the actual smoking status. In other words, non-
responses might be more likely to be smoking. For such
situation, assuming non-responses to be missing at
random is not proper and may introduce bias. Instead
of coding all non-responses as smoking or non-smoking,
we treat the missing as nonignorable and apply the
selection modeling approach [5] following the re-
commendation of Hall et al. [2]. Parameter estimation




Ellerbeck et al. [4] developed the KanQuit program, a
2-year randomized trial for smoking cessation delivered to
rural smokers who consumed at least 10 cigarettes per day.
All participants provided written informed consent. The
Human Subjects Committee at The University of Kansas
Medical Center approved the study (HSC# 9196). In this
study, 750 adult participants, regardless of whether they
were interested in stopping smoking, were recruited from
rural primary care clinics across Kansas and randomized to
one of three intervention groups: pharmacotherapy man-
agement alone (PM), pharmacotherapy management plus
1 – 2 counseling calls every 6 month (moderate-
intensity disease management, or MDM), or pharmacother-
apy management supplemented with up to 6 counseling
calls every 6 month (high-intensity disease management, or
HDM). The primary outcome, the self-reported 7-day
abstinence (defined as not having smoked a cigarette during
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baseline to 24 months. As in many longitudinal studies,
participants did not always respond and only 76% (552 indi-
viduals) responded at every time point.
Covariates obtained at enrollment included (1) demo-
graphic variables: age, gender, marital status, education
level, annual household income, and the presence of
children either ≤ 18 years or ≤ 6 years of age, (2) smoking
characteristics: number of cigarettes smoked per day,
nicotine dependence (time to first cigarette after waking
up), (3) environmental smoking factors: number of
friends that smoke, partner smoking status, whether
anyone else smoked at home, and home smoking rules,
and (4) psychosocial characteristics: global motivation to
quit, confidence to quit, smoking self-efficacy question-
naire (SEQ) score, and whether they had made serious
quit attempts in the past 6 months. Motivation and con-
fidence to quit were assessed using 11-point (0 to 10)
Likert scale measures, with greater scores indicating
stronger motivation/confidence to quit smoking. The
SEQ involves 12 items to assess participants’ confidenceTable 1 Baseline characteristics of 750 study participants
Characteristic Total (n = 750)
Demographic
Age, mean (SD) 47.2 (13.1)
Female, counts (%) 439 (58.5)
Marital: Married/partners (vs. others), counts (%) 504 (67.2)
Education: High school or less, counts (%) 385 (51.3)
Annual income ≤ 40 K, counts (%)* 453 (61.4)
Child under 18 (vs. no), counts (%) 294 (39.2)
Child under 6 (vs. no), counts (%) 106 (14.1)
Smoking
Cigarettes smoked per day (CPD), mean (SD) 23.7 (10.4)
Nicotine dependence (time to first cigarette):
within 5 minutes after waking up, counts (%)
285 (38.0)
Number of friends that smoked:
< 3 friends (vs. ≥ 3 friends), counts (%)
289 (38.5)
Partner smoked? counts (%) 309 (41.2)
Other smokers at home? counts (%) 345 (46.0)
Home smoking rules
Not allowed, counts (%) 204 (27.2)
Allowed some place, counts (%) 205 (27.3)
No rules (reference)
Psychosocial
Motivation to quit score (MOT), mean (SD) 8.6 (2.1)
Confidence to quit score (CON), mean (SD) 6.1 (2.7)
Smoking Self-Efficacy total score, mean (SD) 32.9 (10.7)
Serious quit attempt (SQA), counts (%) 180 (24.0)
* 12 participants did not respond.in their ability to refrain from smoking. These baseline
characteristics are summarized in Table 1. Detailed
information about the study design and covariates can
be found in [4] and [7].
The Markov chain model
Consider a typical randomized trial in which participants
are all smokers at enrollment (t = 0) and scheduled to
have T follow-up visits with equal intervals after the
treatment. Let Yi;t denote the smoking status, which
takes value 1 if the status is smoking and 0 if abstinent,
for the ith individual at time t , i ¼ 1; 2; . . . ; N and t ¼
0; 1; . . . ; T : In a standard first-order Markov chain
model, two assumptions are required: (1) the Markov
property and (2) the stationary transition process.
The Markov property refers to the probability that an
individual is abstinent (or smoking) at a given time t
depends only on her/his smoking status at the time t 
1 but not on the entire history of observations, i.e.,
Pr Yi;t jYi;t1;Yi;t2; . . . ;Yi;0
  ¼ Pr Yi;t jYi;t1 : The as-
sumption of stationary transition process refers toPM (n = 250) MDM (n = 249) HDM (n = 251)
47.0 (13.4) 48.2 (12.4) 46.4 (13.5)
144 (57.6) 144 (57.8) 151 (60.2)
170 (68.0) 167 (67.1) 167 (66.5)
128 (51.2) 129 (51.8) 128 (51.0)
155 (63.0) 151 (61.9) 147 (59.3)
97 (38.8) 89 (35.7) 108 (43.0)
33 (13.2) 31 (12.5) 42 (16.7)
24.3 (11.0) 23.8 (10.3) 22.9 (10.0)
93 (37.2) 103 (41.4) 89 (35.5)
99 (39.6) 95 (38.2) 95 (37.9)
110 (44.0) 104 (41.7) 95 (37.9)
119 (47.6) 116 (46.6) 110 (43.8)
65 (26.0) 67 (26.9) 72 (28.7)
70 (28.0) 73 (29.3) 62 (24.7)
8.7 (2.0) 8.6 (2.1) 8.6 (2.0)
5.9 (2.7) 6.1 (2.8) 6.3 (2.6)
31.7 (10.5) 33.4 (11.0) 33.6 (10.5)
56 (22.4) 60 (24.1) 64 (25.5)
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not change over time, i.e. Pr Yi;t ¼ kjYi;t1 ¼ j
  ¼
Pr Yi;s ¼ kjYi;s1 ¼ j
  ¼ πjk for any s 6¼ t . Hence, the







where the first row provides probabilities of transitions
from the state of abstinence at the previous time point
whereas the second row shows transition probabilities
from smoking; πi;10 indicates the probability of be-
coming abstinent (given being smoking previously),
and πi;01 the chance of relapse. Here the subscript i
indicates an allowance for patient-specific transition
probabilities.
The assumption of stationary in time may not be realistic
in practice. A variant model, known as time-inhomogeneous
Markov chain, relaxes the stationary assumption and al-
lows transition probabilities to vary across time, and can
be denoted as πi;jk tð Þ.
To compare the crude treatment effects, one may
compute the transition matrix for each treatment group,
and then test equality of the matrices (see e.g., [8]) or
use the regression method without covariates described
below. When covariates are considered, one may model
the transitions by logistic regression models
logit πi;01 tð Þ ¼ logit Pr Yi;t ¼ 1jYi;t1 ¼ 0
  
¼ x0i;tβ0 1að Þ
logit πi;10 tð Þ ¼ logit Pr Yi;t ¼ 0jYi;t1 ¼ 1
  
¼ x0i;tβ1 1bð Þ
where xi;t is the vector from the design matrix for the i
th
individual at time t, and (1a) and (1b) model relapse and
abstinence of smoking, respectively. Note that covariates
may have different effects in the two models, and β0 and
β1 need not be equal. For ease of communication, we
call (1a) and (1b) as Model (1) thereinafter unless one of
them is specifically discussed.Statistical analysis
We first assume the missing mechanism is ignorable and
analyze the data by Model (1) using the available data.
Variables are selected based upon the Bayesian Informa-
tion Criterion (BIC). We also consider the missing
values to be outcome-dependent and not ignorable, and
perform sensitivity analysis by selection modeling and
jointly model the longitudinal smoking status and the
missing process. Denote Ri;t ¼ 1 if Yi;t was observedand 0 otherwise. Because smoking-intervention trials
typically enroll smokers only, their baseline smoking sta-
tus is observed and Ri;0 ¼ 1. A flexible model for missing
mechanism [9] has the form
logit λi;t ¼ logit Pr Ri;t ¼ 1
  
¼ α0 þ α1ri;t1 þ α2yi;t1 þ α3yi;t
þ xi;t′αx ð2Þ
where xi;t can be any subset of xi;t and αx is the asso-
ciated parameter vector. Thus, α2 ¼ α3 ¼ 0 implies
missing complete at random (MCAR), α3 ¼ 0 and α2 6¼
0 indicate missing at random (MAR), and α3 6¼ 0 repre-
sents not missing at random (NMAR) [10].
The longitudinal smoking status (Models (1)) and the
missing process (Model (2)) are then jointly modeled
and estimated by the EM algorithm. Given all participants
are smokers at enrollment, the complete data likelihood
function L θ;Y;Rð Þ ¼ ΠNi¼1Li θ; yi; rið Þ where α; βð Þ ¼
α0; α1; α2; α3;αx; β0;β1ð Þ , and the contribution of the ith
individual is











For ease of expression, we express yi ¼ yobsi ; ymisi
 
that
respectively indicate observed and missing components.
The E-step of the EM algorithm constructs the condi-
tional expectation of the complete-data log-likelihood
given the observed responses and the v-th iteration of
the parameter estimates Q θ; θ υð Þ
 	















ω υð Þi log Li θ; yi; rið Þ
and ω υð Þi is the weight or the probability that the unob-
served response has values Ymisi ¼ ymisi given the covari-
ates and the parameter estimates at the v-th iteration. In
the M-step, Q θ; θ υð Þ
 	
is maximized with respect to θ
by the Newton–Raphson algorithm. In practice, we start
with initial values of θ 0ð Þ to construct the conditional ex-
pectation Q θ; θ 0ð Þ
 	
which is maximized with respect to
parameters to update θ (θ 1ð Þ ), and then repeat the E-
and the M-steps iteratively until the parameter estimates
converge. The standard error (SE) of parameter esti-
mates are estimated by non-parametric bootstrapping
[11] with 1,000 samples.
Analysis was performed on SAS version 9.2. PROC
NLMIXED was used for analysis on available data. PROC
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estimated by the EM algorithm, and a SAS macro was
developed for bootstrapping (Additional file 1: Appendix).Results
Using available data alone (ignore missing mechanism)
If the assessment of smoking status was complete for
all of the 750 participants, there should have been
750 x 4 = 3000 observations. Nonetheless, these patients
provided 2540 observations, or around 15.3% missing
values. Figure 1 describes the transition of self-reported
smoking status based on available observations for all
the 750 participants. At Month 6, 15.4% of participants
became abstinent. Among these participants who also
self-reported their status at Month 12, 20% regressed to
smoking; among those continued smoking at Month 6
and self-reported at Month 12, 12.3% turned to abstin-
ent. Transition probabilities between the other time
points are interpreted in the similar manner. The
proportions of smoking and not smoking at each time
point (based on available data) are shown in parentheses
within each box. The group-specific probabilities can be
found in Table 3 of [4]. Results of using available data
alone in the Markov model suggest that the crude inter-
vention effects were significantly different across treat-
ment arms in promoting smoking abstinence ( F2;2540 =
5.16, p = 0.006), but not in preventing relapse (F2;2540 =
1.72, p = 0.179). When covariates were considered in the
model, some covariates were also significantly associated
with transitions from smoking to abstinence and some
other covariates from abstinent to smoking:Model (1a) Transition from smoking to abstinent
Given smoking currently, the odds in favor of abstinence
in the next 6 month was higher among male smokers than
females (OR = e0:504 = 1.66, p=0.0002, Table 2), among
smokers consuming fewer cigarettes per day at baseline
(OR = e 0:033ð Þ = 1.03, p< 0.0001), among those with
higher motivation and confidence (OR = e0:144 = 1.15,
p< 0.0001 and OR = e0:083 = 1.09, p= 0.0014, respectively),
and among those who had serious attempt to quit (OR =Enrollment 6 Months 12 Mon
   Smoking Smoking           Smok
                                                 (84.6%)                                 (77.1
          Not smoking        Not smo







Figure 1 Transition probabilities of self-reported smoking status basee0:295 = 1.34, p= 0.043). After adjusting for these covariates,
the overall treatment effects were significant (F2;2536= 3.65,
p= 0.026. Note that the degrees of freedom are 2536 due to
4 additional observations without income information).
Specifically, the odds in favor of abstinence in the next
6 month was significantly higher in the HDM arm as com-
pared to the control (PM) group (OR = e0:392 = 1.48,
p= 0.013) and in MDM vs. HDM (OR = e0:3920:056 = 1.40,
p = 0.037) at 0.05 significance level, but not between MDM
and PM (OR = e0:056 = 1.06, p = 0.74). The temporal
variation in transition to abstinence was not significant
(e0:056 = 1.63, p = 0.180, results not shown).Model (1b) Transition from abstinent to smoking
Among the participants not currently smoking, those with
lower income (OR = e 0:564ð Þ = 1.76, p = 0.029) and
stronger nicotine dependence (i.e. first cigarette within
5 minutes after waking up) at baseline were more likely to
have relapse (OR = e0:588 = 1.80, p = 0.029) in the next
6 month as compared to their counterparts. Note the sig-
nificant time effects (F2;2536 = 4.89, p = 0.008), indicating
that the relapse rates changed over time (Figure 1). After
adjusting for temporal variation and income as well as
nicotine dependence, the overall effects on preventing re-
lapse were still not significant (F2;2536 = 2.30, p = 0.100)
though relapse seemed to be less likely in the MDM
group as compared to the PM group (OR = e0:763 =
0.49, p = 0.033).Sensitivity analysis
In sensitivity analysis, we consider a couple of possible
missing mechanisms and present only two of them in
Table 2. In one analysis (Selection modeling 1), we assume
missingness depends on whether the smoking status is
observed at the previous time point ( Rt1 ), the actual
smoking status at previous (Yt1 ) and current time point
(Yt ); in the other analysis, we further consider time and
treatment arms in the missing model. In either case, the
conclusion of significance remains the same.
The missing mechanism model should be interpreted
with caution. Apparently, missingness significantly dependsths 18 Months 24 Months
ing        Smoking     Smoking 
%)   (77.9%)                               (71.0%) 
king     Not smoking  Not smoking 









d on the available observations.
Table 2 Transition model estimates of abstinence and relapse to smoking
Available data only} Selection modeling 1 Selection modeling 2
Estimate SE p-value Estimate SE p-value Estimate SE p-value
Transition model
From smoking to abstinent (abstinence model)
Intercept -3.348 0.456 < 0.0001 -3.381 0.503 < 0.0001 -3.382 0.502 < 0.0001
MDM 0.056 0.166 0.737† -0.026 0.193 0.446 -0.022 0.188 0.453
HDM 0.392 0.158 0.013† 0.322 0.177 0.034 0.329 0.171 0.027
Gender 0.504 0.137 0.0002 0.461 0.158 0.002 0.462 0.157 0.002
Cigarettes per day -0.033 0.008 < 0.0001 -0.035 0.009 < 0.0001 -0.035 0.009 < 0.0001
Motivation to quit 0.144 0.040 0.0004 0.150 0.044 0.0003 0.150 0.044 0.0003
Confidence to quit 0.083 0.026 0.0014 0.083 0.028 0.002 0.083 0.028 0.002
Serious quit attempt 0.295 0.146 0.043 0.333 0.164 0.021 0.332 0.164 0.021
From abstinent to smoking (relapse model)
Intercept -0.939 0.338 0.006 -0.979 0.376 0.005 -0.977 0.377 0.005
Month 18 0.763 0.318 0.016* 0.792 0.306 0.005 0.788 0.301 0.004
Month 24 -0.029 0.342 0.933* -0.012 0.331 0.486 -0.009 0.332 0.489
MDM -0.708 0.331 0.033{ -0.624 0.372 0.047 -0.629 0.375 0.047
HDM -0.409 0.305 0.181{ -0.366 0.361 0.155 -0.371 0.363 0.153
Income (> 40 K vs. ≤ 40 K) -0.564 0.259 0.029 -0.575 0.308 0.031 -0.576 0.307 0.030
First cigarette (≤ vs. > 5 min) 0.588 0.269 0.029 0.600 0.322 0.031 0.601 0.322 0.031
Missing model
Intercept — — — -0.527 0.339 0.060 -0.626 0.432 0.074
Month 12 — — — — — — 0.366 0.196 0.031
Month 18 — — — — — — 0.072 0.176 0.341
Month 24 — — — — — — 0.597 0.193 0.001
MDM — — — — — — -0.416 0.164 0.006
HDM — — — — — — -0.496 0.173 0.002
Rt1 — — — 3.240 0.191 < 0.0001 3.367 0.194 < 0.0001
Yt1 — — — 0.013 0.319 0.484 0.067 0.287 0.408
Yt — — — -0.428 0.532 0.211 -0.402 0.443 0.182
} -2 log-L = 1944.4; AIC = 1974.4; BIC = 2062.0;
† Overall treatment effects (F2;2536= 3.65, p = 0.026); * time (F2;2536= 4.69, p = 0.009); { overall treatment (F2;2536= 2.31, p = 0.099).
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0.002 for the MDM vs. PM and HDM vs. PM, respectively),
but not on Yt-1 or Yt in either sensitivity analysis, so the
missing mechanism seems to be MCAR. However, when
the missing process is jointly modeled with the repeated
outcome measures, various parameter values may come to
the same likelihood. In other words, even if the transition
and the missing models are correctly specified, joint model-
ing can reduce bias in parameter estimates of the transition
model, but may not do so in those of the missing model.
The missing model parameters may take a wide range of
values and the estimates may be biased. This issue is known
as the “identifiability” problem (see e.g. [12] and [13]).
Hence, some literature only reports the results for the mainoutcome model but not the missing model (see e.g. [13]
and [14]).
Discussion
In this work, we applied a Markov chain model to study
the transitions from smoking to abstinence and from
abstinence to smoking among the 750 patients in the
KanQuit trial. Different factors associated with each type of
transition were identified: gender, the baseline daily
cigarettes consumption, the baseline motivation and confi-
dence to quit, as well as having serious attempt to quit were
associated with transitions from smoking to abstinent,
whereas income and nicotine dependence were associated
with relapse. The intervention effects were significant in
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(in spite of the MDM group showing a trend of a lower
relapse rate), which is probably due to the fact that too few
observations of such transitions were available. The sensi-
tivity analyses confirmed the conclusion.
Cox et al. [15] studied the predictors of smoking
abstinence at Month 6 and Month 24, separately, using
the 592 participants who completed the assessment at
both time points. They identified male gender and lower
baseline daily cigarettes consumption. They did not
find intervention effects significant at either time point.
Ellerbeck et al. [4] applied the GLMM to evaluate an
individual’s odds in favor of abstinence in treatment
arms (without covariates), with and without imputation
(single imputation of coding all missing to be smoking
and not smoking, respectively), and found a significantly
higher odds in the HDM group than PM, but not
between MDM and PM, or between the two interven-
tion groups, except when all missing were coded as
smoking. These findings seem to be consistent with the
current work (the portion of transitions from smoking
to abstinent or Model (1a)), but the interpretations are
different. The GLMM (specifically the random intercept
model) suggests that the odds in favor of abstinence for
an individual in the HDM group was higher than the
odds if the same individual were in the PM group, assum-
ing the intervention effects were the same for all indivi-
duals. On the other hand, the transition model indicates
that (1) among participants who were smoking at a given
time point, the odds in favor of abstinence in the next
6-month was higher in the HDM than the PM group, in
males than females, in those with higher motivation and
confidence to quit, and in those having serious attempts
to quit; and (2) among participants who were abstinent at
a given time point, the odds of relapse in the next
6-month was greater at Month 18 (see Figure 1), and
among those with lower income and stronger nicotine
dependence. Note that relapse refers to turning from
abstinence to smoking, thus analysis of relapse must
confine to information of participants who ever quitted at
some time point(s).
As mentioned in Introduction, GEE and GLMM may
estimate the population abstinence rate or an individual’s
chance of not smoking, respectively, but they do not pro-
vide the relapse rates which are conditional probabilities.
Note that subtracting the abstinence rate or an individual’s
chance of not smoking from 100% does not give the
relapse rate because this number can include participants
who ever quitted smoking and those who never. If a
smoker continued smoking without abstinence until the
observed time, we wouldn’t consider this observation as
relapse. This limitation in GEE or GLMM is a strength of
transition models. Another strength of Markov models is,
when the outcome is multinomial, Markov models mayestimate parameters more accurately and provide greater
power in rejecting the null hypothesis than GEE [16].
Moreover, the transition models may serve as an
intervention diagnostic tool, which can be particularly
beneficiary for studies failing to show significant inter-
vention effects in abstinence rates. An intervention may
fail because either it does not motivate smokers to stop
smoking, or it does motivate abstinence but fails to
prevent relapse. This question can be answered by the
transition patterns shown in Figure 1 and Markov models.
Researchers may examine the factors associated with the
transitions in both directions, and modify the intervention
by incorporating these factors. In the KanQuit example, the
results suggest that on the basis of the current disease
management interventions, the intervention effects may be
further improved by enhancing smokers’ motivation and
confidence to quit and quit attempts, as well as reducing
baseline daily cigarette consumption and/or nicotine
dependence.
In the sensitivity analysis (Table 2), we note that the
current and previous smoking status are not significant in
the missing models. However, it is still premature to claim
that missing was ignorable. In fact, even though missing is
non-ignorable, the impact of missing values may be mild to
moderate in some occasions. When observations are
strongly correlated, we may borrow the information from
the observed values at the neighboring time points to
predict the missing values, and the bias due to the missing
values can be reduced ([17], Section 2.5). Similarly, for the
Markov chain models, a strong association among the
repeated measures or strong dependence of current obser-
vations on previous observations may reduce bias in
estimation due to non-ignorable missing [18]. In this study,
high probabilities of staying in a current state (from
smoking to smoking and from abstinent to abstinent
in Figure 1) suggest strong dependence of current states
on the previous ones, which helped reduce the impact of
non-ignorable non-responses.
As mentioned earlier, non-responses can be caused by
various reasons and the true missing mechanism cannot
be determined by the data at hand. If ignorable missing
can be justified, an alternative approaches to handle
missing values are to apply multiple imputation [17,19]
or the multi-step transition probabilities [8]. The prob-
abilities of transitions between two consecutive time
points, as described in the Method section, are called
the one-step probabilities. When missing values exist,
one should consider all possible states for the missing
values and sum up the one-step probabilities for all
possible routes to obtain the multi-step transition prob-
abilities. This approach may reduce SE and increase
statistical power as the EM algorithm [20].
Another issue is about the validity of self-report smok-
ing status. Ellerbeck et al. [4] showed deviation in
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validated saliva cotinine levels (threshold of 15 ng/mL)
among the 58% participants who provided saliva sam-
ples. When measurements are subject to errors, data are
often analyzed by latent variable methods such as hidden
Markov models [18] or latent transition analysis (LTA)
[21-23]. We also attempted to fit the KanQuit data by
the LTA [24]. However, the LTA model did not seem to
fit the data better than the conventional Markov model,
and the results are contradictory to our understanding
(nearly no chance of relapse and participants would have
14.8% chance of incorrectly reporting they were smoking
when they were actually not). Therefore, the results are
not presented in this work.
Conclusions
In this article, we discuss and demonstrate how a Markov
chain model may use the information in randomized
smoking cessation trials that the GEE or mixed-effects
models do not utilize, and provide additional findings.
With the Markov chain model, we are able to learn about
the factors associated with relapse to smoking among those
who are temporarily abstinent as well as the factors asso-
ciated with abstinence. Therefore, to fully investigate longi-
tudinal smoking cessation randomized trials, we encourage
researchers to apply transition models together with either
GEE or GLMM. GEE or GLMM compares treatment
effects between intervention groups and examines the
temporal profiles of the treatment effects; Markov models
provide knowledge about transitions between abstinence
and relapse in both directions. This knowledge may
provide guidance in evaluating and designing more effect-
ive interventions for smoking cessation and relapse preven-
tion. When non-response causes considerable missing
values (e.g. 10% or more) and if non-ignorable missing is
considered, sensitivity analysis based on a couple of miss-
ing mechanisms should be examined. The results of the
missing model should be interpreted with caution.
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